Current assets increased 25.8%
Current assets changed +25.8% from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes.
Ranked by interpretable importance, issuer history, magnitude, and accounting profile. No directional recommendation.
Current assets changed +25.8% from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes.
Cash & equivalents changed +101.2% from the comparable as-filed period. The change ranks at the 75th percentile of 4 prior comparable changes.
Operating margin changed +1228 basis points from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
Free-cash-flow proxy changed +121.7% from the comparable as-filed period.
Operating cash flow changed +96.7% from the comparable as-filed period.
Working capital changed +18.5% from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes.
Gross margin changed +1194 basis points from the comparable as-filed period.
Operating income changed +224.0% from the comparable as-filed period. Relative percentage is de-emphasized because the comparison has a sign change. This reverses 2 consecutive comparable moves in the opposite direction.
Current liabilities changed +29.6% from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes.
Gross profit changed +21.7% from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
Net income changed +211.7% from the comparable as-filed period. Relative percentage is de-emphasized because the comparison has a sign change. This reverses 2 consecutive comparable moves in the opposite direction.
Capital expenditure changed +51.4% from the comparable as-filed period.
Operating cash-flow margin changed +726 basis points from the comparable as-filed period.
Free-cash-flow margin changed +589 basis points from the comparable as-filed period.
Stock-based compensation changed -30.3% from the comparable as-filed period.
Capex / revenue changed +137 basis points from the comparable as-filed period.
Total assets changed +9.2% from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes.
Revenue changed +0.4% from the comparable as-filed period.
Working capital / assets changed +112 basis points from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes. This reverses 4 consecutive comparable moves in the opposite direction.
Research & development changed -14.3% from the comparable as-filed period.
SBC / revenue changed -63 basis points from the comparable as-filed period.
Shares outstanding changed -1.3% from the comparable as-filed period. The change ranks at the 29th percentile of 7 prior comparable changes.
Selling, general & administrative changed +0.3% from the comparable as-filed period.
Current ratio changed -2.9% from the comparable as-filed period. The change ranks at the 25th percentile of 4 prior comparable changes.
R&D / revenue changed -19 basis points from the comparable as-filed period.
Cash & equivalents changed +111.9% from the comparable as-filed period.
Operating margin changed -176 basis points from the comparable as-filed period.
Free-cash-flow proxy changed +19.2% from the comparable as-filed period.
Operating income changed -16.2% from the comparable as-filed period.
Gross margin changed -166 basis points from the comparable as-filed period.
Capex / revenue changed -256 basis points from the comparable as-filed period.
Operating cash flow changed +14.6% from the comparable as-filed period.
Capital expenditure changed -41.4% from the comparable as-filed period.
Free-cash-flow margin changed +688 basis points from the comparable as-filed period.
Operating cash-flow margin changed +432 basis points from the comparable as-filed period.
Current liabilities changed +13.5% from the comparable as-filed period.
Shares outstanding changed +0.6% from the comparable as-filed period. The change ranks at the 14th percentile of 7 prior comparable changes. This reverses 6 consecutive comparable moves in the opposite direction.
Revenue changed -0.1% from the comparable as-filed period.
Total assets changed +3.6% from the comparable as-filed period.
Current assets changed +9.7% from the comparable as-filed period.
Working capital changed +3.3% from the comparable as-filed period. This reverses 3 consecutive comparable moves in the opposite direction.
Net income changed -2.3% from the comparable as-filed period.
Stock-based compensation changed -16.0% from the comparable as-filed period.
Gross profit changed -3.2% from the comparable as-filed period.
SBC / revenue changed -29 basis points from the comparable as-filed period.
Selling, general & administrative changed +2.2% from the comparable as-filed period.
Research & development changed -4.5% from the comparable as-filed period.
Stockholders' equity changed +2.1% from the comparable as-filed period.
Working capital / assets changed -4 basis points from the comparable as-filed period.
Current ratio changed -3.4% from the comparable as-filed period.
R&D / revenue changed -7 basis points from the comparable as-filed period.
Method Importance combines metric-family relevance, magnitude, issuer-history unusualness, persistence, and financial-statement significance. It is analytical prioritization, not a legal materiality conclusion or investment signal.